Hypothermia
Conditions
Brief summary
Researchers are proposing a pilot randomized controlled trial evaluating the benefit of immediately warming preterm babies using a warming mattress and a plastic wrap, while delaying clamping the umbilical cord at the time of c-section in babies born between 32 and 36 weeks to determine if it reduces the risk of hypothermia.
Detailed description
The trial will be advertised and introduced to patients admitted to the OU Children's Hospital labor and delivery or antepartum units by research nurses. Interested participants will be consented. Researchers are choosing to only include patients undergoing non-emergent cesarean in order to improve their ability to control parameters such as room temperature and labor-related clinical or subclinical maternal infection, which are known confounders. Further, they are limiting their investigation to fetuses 32-36 weeks gestation, since this population represents the largest preterm delivery population. Recruitment and randomization will be stratified by gestational age with an aim to enroll at least 44 pregnancies at 32-34 weeks and 6 days and 20 pregnancies between 35-36 weeks and 6 days. Last, it is impossible to recruit patients outside of the inpatient setting for a study investigating preterm delivery, as such deliveries are rarely predictable in the outpatient setting. There will only be one site for this study, the OU Children's Hospital labor and delivery and antepartum units. The proposed study is a pragmatic randomized controlled pilot trial of neonatal warming techniques with participants allocated in a 1:1 ratio using a random block allocation table using blocks of size 4 and 6 that are stratified by gestational age ranges of 35-36 weeks and 6 days and 32-34 weeks and 6 days. Since there cannot be a placebo intervention, neither the patient nor the neonatal team will be blinded to the group assignment. The group assignments will be made and coded by a third party at the time of randomization. Patients will be randomized to their respective groups immediately prior to surgery. The surgical technician will be provided with the necessary neonatal wraps and mattresses in a sterile fashion, and they will ensure these are available on the surgical field once the cesarean has begun. In the intervention group, the thermal mattress will be activated immediately prior to hysterotomy and placed on the sterile field with delivery of the infant directly onto the mattress. The infant will be dried, stimulated and bulb suctioned as deemed necessary per standard of care followed by wrapping. In the non-intervention group, the infant will be delivered onto the sterile field, dried and suctioned as deemed necessary per OU standard. Cord clamping will be delayed for 60 seconds in all infants under the supervision of both the obstetrician and the neonatal resuscitation team. If either team believes delayed cord clamping is no longer considered safe, as is usual protocol, the cord will be clamped and cut and the baby will be handed off to the neonatology team. After the infant is handed to the neonatology team along with all group assignment specific materials (neonatal wrap and thermal mattress, if in the intervention group), neonatal temperature will be assessed immediately upon arrival to the resuscitation warmer using a digital thermometer placed in the axillary space. Infant temperature will be recorded at 1) arrival to the warmer, 2) after the neonatologist deems that in-room resuscitation is complete and 3) at admission to the Neonatal Intensive Care Unit (NICU), Mother Baby Unit (MBU) or Post-Anesthesia Care Unit (PACU) depending on the baby's needs; determined by the resuscitating physicians. These measurements will be recorded by research nurses in a data collection sheet. Further, the research nurse will record the time from delivery to the time it takes for the infant to arrive at the warmer. Upon arrival at the warmer, the mattress and wrap will be removed as neonatal evaluation takes place. As immediate neonatal temperature is not generally discussed with patients unless there is an issue such as concern for infection, neonatal temperature will not be routinely discussed with all participants. Only if there is concern for neonatal infection or if there is hyperthermia (\>37.5 degrees C) will the study results be discussed with the patient.
Interventions
Babies will be warmed with a standard neonatal transport warming mattress immediately after birth.
Babies will be wrapped in a sterile polyethylene wrap prior to arrival at the warmer.
Sponsors
Study design
Intervention model description
1:1 using a block randomization scheme stratified by gestational age
Eligibility
Inclusion criteria
* Patients who have non-emergent cesarean deliveries (defined as at least 2 hours prior to planned cesarean) * Gestational age between 32 weeks and 0 days and 36 weeks and 6 days determined per usual clinical parameters
Exclusion criteria
* Fetal anomalies or death * Maternal diabetes * Neonates with blistering skin conditions * Reversed end diastolic umbilical artery flow * Placental abruption * Chorioamnionitis * Monochorionic multifetal pregnancies * Inability to provide consent * Provider perception that patient is in significant pain and provider perceived contraindications to delayed cord clamping.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Temperature at Arrival to Warmer | 3 minutes | Temperature at arrival to the Warmer |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Temperature at NICU/Recovery | 24 hours | Temperature at admission to NICU/Recovery |
| Peak Bilirubin | Through hospital discharge up to 3 months | Highest bilirubin level of infant based on blood test |
| Duration of Respiratory Support | Through hospital discharge up to 3 months | Duration of respiratory support in the form of intubation or continuous positive airway pressure (if applicable) |
| Length of Delayed Cord Clamp | Up to 60 seconds after birth | Length of delayed cord clamp in seconds |
| Length of Hospital Stay | Through hospital discharge up to 3 months | Length of hospital stay in days |
| Age to Wean to Crib | Through hospital discharge up to 3 months | Age to wean to crib in days |
| Temperature at Exit | 3 minutes | The temperature at exit is only available for n=21 in treatment groups and n=19 in control group. |
| Hypothermia at Completion of Resuscitation | Through hospital discharge up to 3 months | Hypothermia at the Completion of Resuscitation |
| Hypothermia at NICU/Recovery | Through hospital discharge up to 3 months | Hypothermia at NICU admission /Recovery |
| Hyperthermia (>37.5C) at Warmer | Through hospital discharge up to 3 months | Hyperthermia (\>37.5C) at arrival to Warmer |
| Hypoglycemia | 24 hours | Hypoglycemia (less than 30mg/dL in the first 24 hours) |
| Need for NICU Admission | 24 hours | Whether or not infant was admitted to NICU |
| Composite | Through hospital discharge up to 3 months | Composite neonatal morbidity (if applicable) |
| Hypothermia at Warmer | Immediately after cord clamping (up to 60 seconds after birth) | Number of infants with hypothermia at time of arrival to warmer |
Countries
United States
Participant flow
Pre-assignment details
The values reported reflect the total number of unique participants (mothers) assigned to each Arm.
Participants by arm
| Arm | Count |
|---|---|
| Intervention Group In the intervention group, the infant will be placed on the thermal mattress, then wrapped.
Neonatal warming mattress: Babies will be warmed with a standard neonatal transport warming mattress immediately after birth.
Sterile polyethylene wrap: Babies will be wrapped in a sterile polyethylene wrap prior to arrival at the warmer. | 25 |
| Control Group In the non-intervention group, the infant will be delivered onto the sterile field as per standard of care. | 25 |
| Total | 50 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Physician Decision | 0 | 2 |
Baseline characteristics
| Characteristic | Total | Intervention Group | Control Group |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 50 Participants | 25 Participants | 25 Participants |
| Body Mass Index (kg/m2) | 33.35 kg/m2 | 34.2 kg/m2 | 32.5 kg/m2 |
| Fetal Complications Death | 0 participants | 0 participants | 0 participants |
| Fetal Complications Fetal Growth Restriction | 5 participants | 1 participants | 4 participants |
| Fetal Complications Oligohydramnios | 3 participants | 1 participants | 2 participants |
| Fetal Complications Polyhydramnios | 1 participants | 1 participants | 0 participants |
| Fetal Complications Sepsis | 2 participants | 1 participants | 1 participants |
| Fetal Complications Twins | 6 participants | 3 participants | 3 participants |
| Gestational age | 241.6 days STANDARD_DEVIATION 11 | 241.0 days STANDARD_DEVIATION 10.8 | 242.1 days STANDARD_DEVIATION 11.1 |
| Maternal Age | 30.3 years STANDARD_DEVIATION 6.3 | 31.9 years STANDARD_DEVIATION 6.4 | 28.7 years STANDARD_DEVIATION 6.2 |
| Maternal Complications Chronic Hypertension | 16 participants | 10 participants | 6 participants |
| Maternal Complications Eclampsia | 0 participants | 0 participants | 0 participants |
| Maternal Complications Gestational Hypertension | 4 participants | 2 participants | 2 participants |
| Maternal Complications HELLP | 0 participants | 0 participants | 0 participants |
| Maternal Complications None | 6 participants | 3 participants | 3 participants |
| Maternal Complications Preeclampsia Without Severe Features | 3 participants | 0 participants | 3 participants |
| Maternal Complications Preeclampsia With Severe Features | 18 participants | 8 participants | 10 participants |
| Maternal Complications Thyroid Disorder | 2 participants | 0 participants | 2 participants |
| Maternal Labor | 12 participants | 5 participants | 7 participants |
| Meconium Stain | 0 participants | 0 participants | 0 participants |
| NICU Admission | 34 participants | 16 participants | 18 participants |
| Number of prenatal visits | 6.6 visits STANDARD_DEVIATION 3.2 | 6.5 visits STANDARD_DEVIATION 3 | 6.6 visits STANDARD_DEVIATION 3.3 |
| Payor Status Government/Self | 29 participants | 14 participants | 15 participants |
| Payor Status Private | 21 participants | 11 participants | 10 participants |
| Race/Ethnicity, Customized American Indian/Alaska Native | 3 Participants | 2 Participants | 1 Participants |
| Race/Ethnicity, Customized Asian | 1 Participants | 0 Participants | 1 Participants |
| Race/Ethnicity, Customized Black or African American | 4 Participants | 2 Participants | 2 Participants |
| Race/Ethnicity, Customized Ethnicity Unknown or Not Reported | 7 Participants | 4 Participants | 3 Participants |
| Race/Ethnicity, Customized Hispanic or Latino | 11 Participants | 4 Participants | 7 Participants |
| Race/Ethnicity, Customized Not Hispanic or Latino | 32 Participants | 17 Participants | 15 Participants |
| Race/Ethnicity, Customized Unknown/Not Reported | 12 Participants | 5 Participants | 7 Participants |
| Race/Ethnicity, Customized White | 30 Participants | 16 Participants | 14 Participants |
| Recevied Prenatal Care | 46 participants | 23 participants | 23 participants |
| Rupture of Membranes | 20 participants | 8 participants | 12 participants |
| Sex: Female, Male Female | 50 Participants | 25 Participants | 25 Participants |
| Sex: Female, Male Male | 0 Participants | 0 Participants | 0 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk |
|---|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 25 | 0 / 25 | 1 / 25 | 1 / 25 |
| other Total, other adverse events | 0 / 25 | 0 / 25 | 2 / 25 | 1 / 25 |
| serious Total, serious adverse events | 0 / 25 | 0 / 25 | 0 / 25 | 0 / 25 |
Outcome results
Temperature at Arrival to Warmer
Temperature at arrival to the Warmer
Time frame: 3 minutes
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Intervention Group | Temperature at Arrival to Warmer | 36.9 degrees Celsius |
| Control Group | Temperature at Arrival to Warmer | 37.0 degrees Celsius |
Age to Wean to Crib
Age to wean to crib in days
Time frame: Through hospital discharge up to 3 months
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Intervention Group | Age to Wean to Crib | 3.0 days |
| Control Group | Age to Wean to Crib | 1.0 days |
Composite
Composite neonatal morbidity (if applicable)
Time frame: Through hospital discharge up to 3 months
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Intervention Group | Composite | 1 participants |
| Control Group | Composite | 1 participants |
Duration of Respiratory Support
Duration of respiratory support in the form of intubation or continuous positive airway pressure (if applicable)
Time frame: Through hospital discharge up to 3 months
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Intervention Group | Duration of Respiratory Support | 114.3 hours |
| Control Group | Duration of Respiratory Support | 31.2 hours |
Hyperthermia (>37.5C) at Warmer
Hyperthermia (\>37.5C) at arrival to Warmer
Time frame: Through hospital discharge up to 3 months
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Intervention Group | Hyperthermia (>37.5C) at Warmer | 2 participants |
| Control Group | Hyperthermia (>37.5C) at Warmer | 1 participants |
Hypoglycemia
Hypoglycemia (less than 30mg/dL in the first 24 hours)
Time frame: 24 hours
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Intervention Group | Hypoglycemia | 4 participants |
| Control Group | Hypoglycemia | 3 participants |
Hypothermia at Completion of Resuscitation
Hypothermia at the Completion of Resuscitation
Time frame: Through hospital discharge up to 3 months
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Intervention Group | Hypothermia at Completion of Resuscitation | 6 participants |
| Control Group | Hypothermia at Completion of Resuscitation | 3 participants |
Hypothermia at NICU/Recovery
Hypothermia at NICU admission /Recovery
Time frame: Through hospital discharge up to 3 months
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Intervention Group | Hypothermia at NICU/Recovery | 7 participants |
| Control Group | Hypothermia at NICU/Recovery | 11 participants |
Hypothermia at Warmer
Number of infants with hypothermia at time of arrival to warmer
Time frame: Immediately after cord clamping (up to 60 seconds after birth)
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Intervention Group | Hypothermia at Warmer | 6 participants |
| Control Group | Hypothermia at Warmer | 2 participants |
Length of Delayed Cord Clamp
Length of delayed cord clamp in seconds
Time frame: Up to 60 seconds after birth
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Intervention Group | Length of Delayed Cord Clamp | 61.0 seconds |
| Control Group | Length of Delayed Cord Clamp | 62.0 seconds |
Length of Hospital Stay
Length of hospital stay in days
Time frame: Through hospital discharge up to 3 months
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Intervention Group | Length of Hospital Stay | 11.0 days |
| Control Group | Length of Hospital Stay | 7.0 days |
Need for NICU Admission
Whether or not infant was admitted to NICU
Time frame: 24 hours
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Intervention Group | Need for NICU Admission | 16 participants |
| Control Group | Need for NICU Admission | 18 participants |
Peak Bilirubin
Highest bilirubin level of infant based on blood test
Time frame: Through hospital discharge up to 3 months
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Intervention Group | Peak Bilirubin | 9.0 mg/dl |
| Control Group | Peak Bilirubin | 9.0 mg/dl |
Temperature at Exit
The temperature at exit is only available for n=21 in treatment groups and n=19 in control group.
Time frame: 3 minutes
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Intervention Group | Temperature at Exit | 36.8 degrees Celsius |
| Control Group | Temperature at Exit | 36.7 degrees Celsius |
Temperature at NICU/Recovery
Temperature at admission to NICU/Recovery
Time frame: 24 hours
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Intervention Group | Temperature at NICU/Recovery | 36.6 degrees Celsius |
| Control Group | Temperature at NICU/Recovery | 36.5 degrees Celsius |